The Impact of Diabetes on Epithelial Ovarian Cancer Survival

Backgrounds: Objective Diabetes mellitus (DM) is associated with poorer outcomes in some cancers. Its effect on ovarian cancer is less clear. We consider the effect of DM on overall survival (OS) and progression free survival (PFS) in patients with epithelial ovarian cancer (EOC).Material and method : Methods A retrospective cohort study of 215 patients with EOC diagnosed between 2009 and 2016 was performed. Records were reviewed for standard demographic, pathologic and DM diagnosis data. Cox regression was used to evaluate the relationship between disease status and survival after adjustment for age, body mass index (BMI), parity, stage, grade, histology, debulking status, HTN, menopause status and neoadjuant chemotherapy.Result: Patients with DM (27.97, 95%CI: 23.63 to 32.30) had a significantly shorter OS rates compared to patients without DM (41.01, 95%CI: 38.84 to 43.17). The unadjusted hazard ratio (HR) for the association between OS time and DM was 4.76 (95%CI: 2.99 to 7.59, P<0.001). Following adjustment for demographic and pathologic variables, the HR was 3.98 (95% CI 2.21 to 7.16; P< 0.001). The PFS in patients with DM (14.10, 95%CI: 11.76 to 16.44) was significantly shorter compared to patients without DM (28.83, 95%CI: 26.13 to 31.54).The unadjusted HR for PFS and DM was 5.69 (95% CI: 3.05 to 10.61; P<0.001). After adjustment for demographic and pathologic variables, the HR was 2.84 (95% CI: 1.27 to 6.32; P< 0.001).Conclusion: Conclusions DM can negatively effect on PFS and OS in EOC patients independent of the effect of other variables.